Received Mar 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | UNK | IM / LA |
woke up with a stuffy nose; Cough; Headache; she had a sore throat; This non-serious case was reported by a consumer and described the occurrence of sore throat in a 60-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On 24-FEB-2025, the patient received the 1st dose of Shingles vaccine (intramuscular, left arm). On 24-FEB-2025, less than a day after receiving Shingles vaccine, the patient experienced sore throat (Verbatim: she had a sore throat). On 25-FEB-2025, the patient experienced nasal stuffiness (Verbatim: woke up with a stuffy nose), cough (Verbatim: Cough) and headache (Verbatim: Headache). On 25-FEB-2025, the outcome of the sore throat was resolved. The outcome of the nasal stuffiness, cough and headache were not resolved. It was unknown if the reporter considered the sore throat, nasal stuffiness, cough and headache to be related to Shingles vaccine. It was unknown if the company considered the sore throat, nasal stuffiness, cough and headache to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 25-FEB-2025 The reporter stated that she received Shingrix the day before reporting. She stated last night she had a sore throat but had gone away. At the time of reporting, she woke up with a stuffy nose, cough and headache that she had not recovered from yet.